Eli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients

Eli Lilly releases positive Phase 3 data for Jaypirca and Retevmo, with trial results supporting potential label expansion.

Eli Lilly's Says Phase 3 BRUIN CLL-322 Trial of Jaypirca (pirtobrutinib), Plus Venetoclax And Rituximab Met Its Primary Endpoint For Relapsed Or Refractory Chronic Lymphocytic Leukemia Or

BRUIN CLL-322 is the first Phase 3 readout in CLL to utilize and outperform a venetoclax-containing control armThis trial predominantly enrolled a patient population previously treated with covalent BTK inhibitors,

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1327

Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1313 to $1327.

Eli Lilly Just Launched Its $149 Obesity Pill

Eli Lilly launches Foundayo weight-loss pill after FDA approval, priced from $149/month, as competition with Novo Nordisk intensifies.

WW International Begins Offering Its GLP-1 Developed With Lilly, Foundayo, Through Its Med+ Platform And Affiliated Medical Groups

Through Weight Watchers Med+, clinically eligible members will be able to access this newly approved medication alongside care from board-certified clinicians, insurance support, and additional tools designed to support

What's Going On With GoodRx Stock Thursday?

GoodRx shares rise after expanding Eli Lilly's GLP-1 access; analysts keep Buy rating ahead of May earnings.

Amazon Pharmacy Rolls Out Same-Day Delivery For Eli Lilly's Foundayo GLP-1 Medication

GoodRx Working With Eli Lilly To Expand Access To FDA-Approved Foundayo At $149/Month

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1 medication,

Eli Lilly Announces Foundayo Is Now Available To Adults With Obesity Or Overweight With Weight-Related Medical Problems Following FDA Approval On April 1

Foundayo is now available via LillyDirect® and telehealth providers and is shipping to retail pharmacies nationwideFoundayo, the only GLP-1 pill for weight loss that can be taken any time of day without food or

Eli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales

Eli Lilly and Co. is facing mounting pressure in India as a surge rise in lower-cost generic alternatives dent sales.